WHO SHOULD TAKE EPZICOM?
Epzicom was approved in 2004 for people with HIV infection. Epzicom has not been carefully studied in children. There are no absolute rules about when to start antiretroviral therapy (ART). You and your health care provider should consider your CD4 cell count, your viral load, any symptoms you are having, and your attitude about taking ART. Fact Sheet 404 has more information about guidelines for the use of ART. Epzicom should not be used by people under 13 years old or people with a damaged liver. If you take Epzicom with other antiretroviral drugs (ARVs), you can reduce your viral load to extremely low levels, and increase your CD4 cell counts. This should mean staying healthier longer. Epzicom provides two drugs in one pill. It can be more convenient to use Epzicom than some other combinations of drugs. This could mean fewer missed doses and better control of HIV. Although lamivudine can be used to treat hepatitis B, a lower dose is used than for HIV. People with HIV infection shoul
